The mammalian DNA replication elongation checkpoint: Implication of Chk1 and relationship with origin firing as determined by single DNA molecule and single cell analyses

Cell Cycle

Volumn 6, Issue 22, 2007, Pages 2760-2767

  Conti, Chiara ^a   Seiler, Jennifer A ^a   Pommier, Yves ^a,b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

ATR Chk1; Camptothecin; DNA replication; Fork progression checkpoint; Molecular combing; S phase checkpoint; Topoisomerase

Indexed keywords

CHECKPOINT KINASE 1; DNA;

CYTOLOGY; DNA REPLICATION; DNA REPLICATION ORIGIN; ENZYME ACTIVATION; HUMAN; MAMMAL; REVIEW;

MAMMALIA;

EID: 37249004667     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.6.22.4932     Document Type: Review

References (55)

1. Takemura H, Rao VA, Sordet O, Furuta T, Miao ZH, Meng L, Zhang H, Pommier Y. Defective Mre11-dependent activation of Chk2 by ataxia telangiectasia mutated in colorectal carcinoma cells in response to replication-dependent DNA double strand breaks. J Biol Chem 2006; 281:30814-23.
2. Machida YJ, Hamlin JL, Dutta A. Right place, right time, and only once: Replication initiation in metazoans. Cell 2005; 123:13-24.
3. Petermann E, Caldecott KW. Evidence that the ATR/Chk1 pathway maintains normal replication fork progression during unperturbed S phase. Cell Cycle 2006; 5:2203-9.
4. Byun TS, Pacek M, Yee MC, Walter JC, Cimprich KA. Functional uncoupling of MCM helicase and DNA polymerase activities activates the ATR-dependent checkpoint. Genes Dev 2005; 19:1040-52.
5. Shimura T, Martin MM, Torres MJ, Gu C, Pluth JM, DeBernardi MA, McDonald JS, Aladjem MI. DNA-PK is involved in repairing a transient surge of DNA breaks induced by deceleration of DNA replication. J Mol Biol 2007; 367:665-80.
6. Lopes M, Foiani M, Sogo JM. Multiple mechanisms control chromosome integrity after replication fork uncoupling and restart at irreparable UV lesions. Mol Cell 2006;21:15-27.
7. MacDougall CA, Byun TS, Van C, Yee MC, Cimprich KA. The structural determinants of checkpoint activation. Genes Dev 2007; 21:898-903.
8. Branzei D, Foiani M. Interplay of replication checkpoints and repair proteins at stalled replication forks. DNA Repair (Amst) 2007; 6:994-1003.
9. Unsal-Kacmaz K, Chastain PD, Qu PP, Minoo P, Cordeiro-Stone M, Sancar A, Kaufmann WK. The human Tim/Tipin complex coordinates an Intra-S checkpoint response to UV that slows replication fork displacement. Mol Cell Biol 2007; 27:3131-42.
10. Seiler JA, Conti C, Syed A, Aladjem MI, Pommier Y. The intra-S-phase checkpoint affects both DNA replication initiation and elongation: Single-cell and -DNA fiber analyses. Mol Cell Biol 2007; 27:5806-18.
11. Aladjem MI. Replication in context: Dynamic regulation of DNA replication patterns in metazoans. Nat Rev Genet 2007; 8:588-600.
12. Hayashi M, Katou Y, Itoh T, Tazumi A, Yamada Y, Takahashi T, Nakagawa T, Shirahige K, Masukata H. Genome-wide localization of pre-RC sites and identification of replication origins in fission yeast. Embo J 2007; 26:1327-39.
13. Lucas I, Palakodeti A, Jiang Y, Young DJ, Jiang N, Fernald AA, Le Beau MM. High-throughput mapping of origins of replication in human cells. EMBO Rep 2007; 8:770-7.
14. Wyrick JJ, Aparicio JG, Chen T, Barnett JD, Jennings EG, Young RA, Bell SP, Aparicio OM. Genome-wide distribution of ORC and MCM proteins in S. cerevisiae: High-resolution mapping of replication origins. Science 2001; 294:2357-60.
15. Yabuki N, Terashima H, Kitada K. Mapping of early firing origins on a replication profile of budding yeast. Genes Cells 2002; 7:781-9.
16. Bensimon AS, Chiffaudel A, Croquette A, Heslot V, Bensimon F, Alignment D. Sensitive detection of DNA by a moving interface. Science 1994; 265:2096-8.
17. Herrick J, Bensimon A. Single molecule analysis of DNA replication. Biochimie 1999;81:859-71.
18. Conti C, Herrick J, Teissier S, Thierry F, Sastre-Garau X, Couturier J, Favre M, Orth G, Bensimon A. Genomic organization of amplified HPV/MYC genes suggests distinct mechanisms of gene amplification and tumorigenesis. Cancer Res 2004; 65:1174-9.
19. Conti C, Sacca B, Herrick J, Lalou C, Pommier Y, Bensimon A. Replication fork velocities at adjacent replication origins are coordinately modified during DNA replication in human cells. Mol Biol Cell 2007; 18:3059-67.
20. Conti C, Herrick J, Bensimon A. Unscheduled DNA replication origin activation at inserted HPV 18 sequences in a HPV-18/MYC amplicon. Genes Chromosomes Cancer 2007; 46:724-34.
21. Rao VA, Conti C, Guirouilh-Barbat J, Nakamura A, Miao ZH, Davies SL, Sacca B, Hickson ID, Bensimon A, Pommier Y. Endogenous {gamma}-H2AX-ATM-Chk2 checkpoint activation in Bloom's syndrome helicase deficient cells is related to DNA replication arrested forks. Mol Cancer Res 2007; 5:713-24.
22. Anglana MAF, Bensimon A, Debatisse M. Dynamics of replication in mammalian somatic cells:nucleotide pool modulates origin choice and interorigin spacing. Cell 2003; 114:385-394.
23. Rao A, Fan AM, Meng L, Doe CL, North PS, Hickson I, Pommier Y. Phosphorylation of BLM, dissociation for topoisomerase IIIα and colocalization with γ-H2AX after topoisomerase I-induced replication damage. Mol Cell Biol 2005; 25:8925-37.
24. Champoux JJ. DNA topoisomerases: Structure, function, and mechanism. Annu Rev Biochem 2001; 70:369-413.
25. Pommier Y, Kohlhagen G, Wu C, Simmons DT. Mammalian DNA topoisomerase I activity and poisoning by camptothecin are inhibited by simian virus 40 large T antigen. Biochemistry 1998; 37:3818-23.
26. Wang JC. Cellular roles of DNA topoisomerases: A molecular perspective. Nat Rev Mol Cell Biol 2002; 3:430-40.
27. Abdurashidova G, Radulescu S, Sandoval O, Zahariev S, Danailov MB, Demidovich A, Santamaria L, Biamonti G, Riva S, Falaschi A. Functional interactions of DNA topoisomerases with a human replication origin. Embo J 2007; 26:998-1009.
28. Pommier Y. Topoisomerase I inhibitors, camptothecins and beyond. Nature Review Cancer 2006, (In press).
29. Miao ZH, Player A, Shankavaram U, Wang YH, Zimonjic D, Lorenzi PL, Liao ZY, Liu H, Shimura T, Zhang H, Meng L, Zhang YW, Kawasaki ES, Popescu NC, Aladjem MI, Godstein DJ, Weinstein JN, Pommier Y. Non-classical functions of human topoisomerase I: Genome-wide and pharmacological analyses. Cancer Res 2007, (In Press).
30. Graves PR, Yu L, Schwarz JK, Gales J, Sausville EA, O'Connor PM, Piwnica-Worms H. The Chk1 protein kinase and the Cdc25C regulatory pathways are targets of the anticancer agent UCN-01. J Biol Chem 2000; 275:5600-5.
31. Ni ZJ, Barsanti P, Brammeier N, Diebes A, Poon DJ, Ng S, Pecchi S, Pfister K, Renhowe PA, Ramurthy S, Wagman AS, Bussiere DE, Le V, Zhou Y, Jansen JM, Ma S, Gesner TG. 4-(Aminoalkylamino)-3-benzimidazole-quinolinones as potent CHK-1 inhibitors. Bioorg Med Chem Lett 2006; 16:3121-4.
32. Tse AN, Schwartz GK. Potentiation of cytotoxicity of topoisomerase I poison by concurrent and sequential treatment with the checkpoint inhibitor UCN-01 involves disparate mechanisms resulting in either p53-independent clonogenic suppression or p53-dependent mitotic catastrophe. Cancer Res 2004; 64:6635-44.
33. Tse AN, Rendahl KG, Sheikh T, Cheema H, Aardalen K, Embry M, Ma S, Moler EJ, Ni ZJ, Lopes de Menezes DE, Hibner B, Gesner TG, Schwartz GK. CHIR-124, a novel potent inhibitor of Chk1, potentiates the cytotoxicity of topoisomerase I poisons in vitro and in vivo. Clin Cancer Res 2007; 13:591-602.
34. Hsiang YH, Hertzberg R, Hecht S, Liu LF. Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I. J Biol Chem 1985; 260:14873-8.
35. Shao RG, Cao CX, Zhang H, Kohn KW, Wold MS, Pommier Y. Replication-mediated DNA damage by camptothecin induces phosphorylation of RPA by DNA-dependent protein kinase and dissociates RPA:DNA-PK complexes. EMBO J 1999; 18:1397-406.
36. Strumberg D, Pilon AA, Smith M, Hickey R, Malkas L, Pommier Y. Conversion of topoisomerase I cleavage complexes on the leading strand of ribosomal DNA into 5′-phosphorylated DNA double-strand breaks by replication runoff. Mol Cell Biol 2000; 20:3977-87.
37. Furuta T, Takemura H, Liao ZY, Aune GJ, Redon C, Sedelnikova OA, Pilch DR, Rogakou EP, Celeste A, Chen HT, Nussenzweig A, Aladjem MI, Bonner WM, Pommier Y. Phosphorylation of histone H2AX and activation of Mre11, Rad50, and Nbs1 in response to replication-dependent DNA-double-strand breaks induced by mammalian DNA topoisomerase I cleavage complexes. J Biol Chem 2003; 278:20303-12.
38. Covey JM, Jaxel C, Kohn KW, Pommier Y. Protein-linked DNA strand breaks induced in mammalian cells by camptothecin, an inhibitor of topoisomerase I. Cancer Res 1989; 49:5016-22.
39. Hardin PE. The circadian timekeeping system of Drosophila. Curr Biol 2005; 15:R714-22.
40. Unsal-Kacmaz K, Mullen TE, Kaufmann WK, Sancar A. Coupling of human circadian and cell cycles by the timeless protein. Mol Cell Biol 2005; 25:3109-16.
41. Park H, Sternglanz R. Identification and characterization of the genes for two topoisomerase I-interacting proteins from Saccharomyces cerevisiae. Yeast 1999; 15:35-41.
42. Gotter AL. Tipin, a novel timeless-interacting protein, is developmentally co-expressed with timeless and disrupts its self-association. J Mol Biol 2003; 331:167-76.
43. Chou DM, Elledge SJ. Tipin and Timeless form a mutually protective complex required for genotoxic stress resistance and checkpoint function. Proc Natl Acad Sci USA 2006; 103:18143-7.
44. Noguchi E, Noguchi C, McDonald WH, Yates IIIrd JR, Russell P. Swi1 and Swi3 are components of a replication fork protection complex in fission yeast. Mol Cell Biol 2004; 24:8342-55.
45. Yoshizawa-Sugata N, Masai H. Human Tim/Timeless-interacting protein, Tipin, is required for efficient progression of S phase and DNA replication checkpoint. J Biol Chem 2007; 282:2729-40.
46. Rhind N. DNA replication timing: Random thoughts about origin firing. Nat Cell Biol 2006; 8:1313-6.
47. Dimitrova DS, Berezney R. The spatio-temporal organization of DNA replication sites is identical in primary, immortalized and transformed mammalian cells. J Cell Sci 2002; 115:4037-51.
48. 1 phase. Mol Cell 1999; 4:983-93.
49. Nakamura H, Morita T, Sato C. Structural organizations of replicon domains during DNA synthetic phase in the mammalian nucleus. Exp Cell Res 1986; 165:291-7.
50. Cook PR. The organization of replication and transcription. Science 1999; 284:1790-5.
51. Rogakou EP, Boon C, Redon C, Bonner WM. Megabase chromatin domains involved in DNA double-strand breaks in vivo. J Cell Biol 1999; 146:905-16.
52. Rogakou EP, Pilch DR, Orr AH, Ivanova VS, Bonner WM. DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J Biol Chem 1998; 273:5858-68.
53. Sedelnikova OA, Rogakou EP, Panyutin IG, Bonner WM. Quantitative detection of (125)IdU-induced DNA double-strand breaks with gamma-H2AX antibody. Radiat Res 2002; 158:486-92.
54. Busby EC, Leistritz DF, Abraham RT, Karnitz LM, Sarkaria JN. The radiosensitizing agent 7-hydroxystaurosporine (UCN-01) inhibits the DNA damage checkpoint kinase hChk1. Cancer Res 2000; 60:2108-12.
55. Norio P, Kosiyatrakul S, Yang Q, Guan Z, Brown NM, Thomas S, Riblet R, Schildkraut CL. Progressive activation of DNA replication initiation in large domains of the immunoglobulin heavy chain locus during B cell development. Mol Cell 2005; 20:575-87.